[4-[4-(3,5-dimethyl-1,2-oxazol-4-yl)-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-1H-indol-6-yl]methanol;4-[4-(1,4-dimethylpyrazol-5-yl)-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-1H-indole-6-carboxylic acid;(3R)-4-[6-(3,5-dimethyltriazol-4-yl)-2-(6-methyl-1H-indol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[4-(3,5-dimethyltriazol-4-yl)-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)-2-pyridinyl]-3-methylmorpholine

C89H97N25O8 — CID 159914441

IUPAC[4-[4-(3,5-dimethyl-1,2-oxazol-4-yl)-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-1H-indol-6-yl]methanol;4-[4-(1,4-dimethylpyrazol-5-yl)-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-1H-indole-6-carboxylic acid;(3R)-4-[6-(3,5-dimethyltriazol-4-yl)-2-(6-methyl-1H-indol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[4-(3,5-dimethyltriazol-4-yl)-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)-2-pyridinyl]-3-methylmorpholine
SMILESCc1cc(-c2nc(-c3c(C)nnn3C)cc(N3CCOC[C@H]3C)n2)c2cc[nH]c2c1.Cc1cnn(C)c1-c1cc(N2CCOC[C@H]2C)nc(-c2cc(C(=O)O)cc3[nH]ccc23)n1.Cc1nnn(C)c1-c1cc(-c2ccnc3[nH]ccc23)nc(N2CCOC[C@H]2C)c1.Cc1noc(C)c1-c1cc(N2CCOC[C@H]2C)nc(-c2cc(CO)cc3[nH]ccc23)n1
InChIInChI=1S/C23H24N6O3.C23H25N5O3.C22H25N7O.C21H23N7O/c1-13-11-25-28(3)21(13)19-10-20(29-6-7-32-12-14(29)2)27-22(26-19)17-8-15(23(30)31)9-18-16(17)4-5-24-18;1-13-12-30-7-6-28(13)21-10-20(22-14(2)27-31-15(22)3)25-23(26-21)18-8-16(11-29)9-19-17(18)4-5-24-19;1-13-9-17(16-5-6-23-18(16)10-13)22-24-19(21-15(3)26-27-28(21)4)11-20(25-22)29-7-8-30-12-14(29)2;1-13-12-29-9-8-28(13)19-11-15(20-14(2)25-26-27(20)3)10-18(24-19)16-4-6-22-21-17(16)5-7-23-21/h4-5,8-11,14,24H,6-7,12H2,1-3H3,(H,30,31);4-5,8-10,13,24,29H,6-7,11-12H2,1-3H3;5-6,9-11,14,23H,7-8,12H2,1-4H3;4-7,10-11,13H,8-9,12H2,1-3H3,(H,22,23)/t14-;13-;14-;13-/m1111/s1
InChIKeyNXPFRDUZLXXKSK-VIZKOGMYSA-N
MW1644.92 g/mol
LogP13.09
Rot. Bonds14

About [4-[4-(3,5-dimethyl-1,2-oxazol-4-yl)-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-1H-indol-6-yl]methanol;4-[4-(1,4-dimethylpyrazol-5-yl)-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-1H-indole-6-carboxylic acid;(3R)-4-[6-(3,5-dimethyltriazol-4-yl)-2-(6-methyl-1H-indol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[4-(3,5-dimethyltriazol-4-yl)-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)-2-pyridinyl]-3-methylmorpholine

[4-[4-(3,5-dimethyl-1,2-oxazol-4-yl)-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-1H-indol-6-yl]methanol;4-[4-(1,4-dimethylpyrazol-5-yl)-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-1H-indole-6-carboxylic acid;(3R)-4-[6-(3,5-dimethyltriazol-4-yl)-2-(6-methyl-1H-indol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[4-(3,5-dimethyltriazol-4-yl)-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)-2-pyridinyl]-3-methylmorpholine (PubChem CID 159914441) has the molecular formula C89H97N25O8 and a molecular weight of 1644.92 g/mol. Its IUPAC name is [4-[4-(3,5-dimethyl-1,2-oxazol-4-yl)-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-1H-indol-6-yl]methanol;4-[4-(1,4-dimethylpyrazol-5-yl)-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-1H-indole-6-carboxylic acid;(3R)-4-[6-(3,5-dimethyltriazol-4-yl)-2-(6-methyl-1H-indol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[4-(3,5-dimethyltriazol-4-yl)-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)-2-pyridinyl]-3-methylmorpholine.

Molecular Properties

Compound Name[4-[4-(3,5-dimethyl-1,2-oxazol-4-yl)-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-1H-indol-6-yl]methanol;4-[4-(1,4-dimethylpyrazol-5-yl)-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-1H-indole-6-carboxylic acid;(3R)-4-[6-(3,5-dimethyltriazol-4-yl)-2-(6-methyl-1H-indol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[4-(3,5-dimethyltriazol-4-yl)-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)-2-pyridinyl]-3-methylmorpholine
PubChem CID159914441
Molecular FormulaC89H97N25O8
Molecular Weight1644.92 g/mol
Exact Mass1643.80
IUPAC Name[4-[4-(3,5-dimethyl-1,2-oxazol-4-yl)-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-1H-indol-6-yl]methanol;4-[4-(1,4-dimethylpyrazol-5-yl)-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-1H-indole-6-carboxylic acid;(3R)-4-[6-(3,5-dimethyltriazol-4-yl)-2-(6-methyl-1H-indol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[4-(3,5-dimethyltriazol-4-yl)-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)-2-pyridinyl]-3-methylmorpholine
SMILESCc1cc(-c2nc(-c3c(C)nnn3C)cc(N3CCOC[C@H]3C)n2)c2cc[nH]c2c1.Cc1cnn(C)c1-c1cc(N2CCOC[C@H]2C)nc(-c2cc(C(=O)O)cc3[nH]ccc23)n1.Cc1nnn(C)c1-c1cc(-c2ccnc3[nH]ccc23)nc(N2CCOC[C@H]2C)c1.Cc1noc(C)c1-c1cc(N2CCOC[C@H]2C)nc(-c2cc(CO)cc3[nH]ccc23)n1
InChIInChI=1S/C23H24N6O3.C23H25N5O3.C22H25N7O.C21H23N7O/c1-13-11-25-28(3)21(13)19-10-20(29-6-7-32-12-14(29)2)27-22(26-19)17-8-15(23(30)31)9-18-16(17)4-5-24-18;1-13-12-30-7-6-28(13)21-10-20(22-14(2)27-31-15(22)3)25-23(26-21)18-8-16(11-29)9-19-17(18)4-5-24-19;1-13-9-17(16-5-6-23-18(16)10-13)22-24-19(21-15(3)26-27-28(21)4)11-20(25-22)29-7-8-30-12-14(29)2;1-13-12-29-9-8-28(13)19-11-15(20-14(2)25-26-27(20)3)10-18(24-19)16-4-6-22-21-17(16)5-7-23-21/h4-5,8-11,14,24H,6-7,12H2,1-3H3,(H,30,31);4-5,8-10,13,24,29H,6-7,11-12H2,1-3H3;5-6,9-11,14,23H,7-8,12H2,1-4H3;4-7,10-11,13H,8-9,12H2,1-3H3,(H,22,23)/t14-;13-;14-;13-/m1111/s1
InChIKeyNXPFRDUZLXXKSK-VIZKOGMYSA-N
XLogP13.09
TPSA378.96 Ų
H-Bond Donors6
H-Bond Acceptors28
Rotatable Bonds14
Heavy Atoms122
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001644.92
LogP ≤ 513.09
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1028

Analyze [4-[4-(3,5-dimethyl-1,2-oxazol-4-yl)-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-1H-indol-6-yl]methanol;4-[4-(1,4-dimethylpyrazol-5-yl)-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-1H-indole-6-carboxylic acid;(3R)-4-[6-(3,5-dimethyltriazol-4-yl)-2-(6-methyl-1H-indol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[4-(3,5-dimethyltriazol-4-yl)-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)-2-pyridinyl]-3-methylmorpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

4-[4-(3,5-dimethyl-1,2-oxazol-4-yl)-6-(3-methylmorpholin-4-yl)pyrimidin-2-yl]-1H-indole-6-carboxylic acid
CID 165437044
[2-cyclopropyl-6-(3,5-dimethyl-1,2-oxazol-4-yl)-1H-benzimidazol-4-yl]-bis(5-fluoro-2-pyridinyl)methanol;[2-cyclopropyl-6-(3,5-dimethyl-1,2-oxazol-4-yl)-1H-benzimidazol-4-yl]-bis(3-methyl-4-pyridinyl)methanol;[2-cyclopropyl-6-(3,5-dimethyl-1,2-oxazol-4-yl)-1H-benzimidazol-4-yl]-(2,5-dimethyl-4-pyridinyl)methanone;[2-cyclopropyl-6-(3,5-dimethyl-1,2-oxazol-4-yl)-1H-benzimidazol-4-yl]-pyridazin-3-ylmethanone;[2-cyclopropyl-6-(3,5-dimethyl-1,2-oxazol-4-yl)-1H-benzimidazol-4-yl]-[6-(trifluoromethyl)pyridazin-3-yl]methanone
CID 158384302
4-[3-[1-(Difluoromethyl)pyrazol-4-yl]-1-(1-pyridin-2-ylethyl)pyrrolo[3,2-b]pyridin-6-yl]-3,5-dimethyl-1,2-oxazole;4-[3-[1-(difluoromethyl)pyrazol-4-yl]-1-(pyrimidin-2-ylmethyl)pyrrolo[3,2-b]pyridin-6-yl]-3,5-dimethyl-1,2-oxazole;4-[3-[1-(2,2-difluoropropyl)pyrazol-4-yl]-1-(pyrimidin-2-ylmethyl)pyrrolo[3,2-b]pyridin-6-yl]-3,5-dimethyl-1,2-oxazole;4-[6-(3,5-dimethyl-1,2-oxazol-4-yl)-1-(1-pyridin-2-ylethyl)pyrrolo[3,2-b]pyridin-3-yl]benzoic acid
CID 160653452
(3R)-4-[6-(3,5-dimethyl-1,2-oxazol-4-yl)-2-(1H-pyrrolo[2,3-b]pyridin-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[6-(1,3-dimethylpyrazol-4-yl)-2-(1H-pyrrolo[2,3-b]pyridin-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[6-(1,5-dimethylpyrazol-4-yl)-2-(1H-pyrrolo[2,3-b]pyridin-4-yl)pyrimidin-4-yl]-3-methylmorpholine;[1-methyl-4-[6-[(3R)-3-methylmorpholin-4-yl]-2-(1H-pyrrolo[2,3-b]pyridin-4-yl)pyrimidin-4-yl]pyrazol-5-yl]methanol;(3R)-3-methyl-4-[6-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]-2-(1H-pyrrolo[2,3-b]pyridin-4-yl)pyrimidin-4-yl]morpholine
CID 160948964
2-bromo-5H-pyrrolo[2,3-b]pyrazine;(4,4-difluorocyclohexyl)-[2-(3,5-dimethyl-1,2-oxazol-4-yl)-5H-pyrrolo[2,3-b]pyrazin-7-yl]methanol;6-[7-[(4,4-difluorocyclohexyl)methyl]-2-(3,5-dimethyl-1,2-oxazol-4-yl)pyrrolo[2,3-b]pyrazin-5-yl]pyridine-3-carboxylic acid;4-[7-[(4,4-difluorocyclohexyl)methyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]-3,5-dimethyl-1,2-oxazole;3,5-dimethyl-4-(5H-pyrrolo[2,3-b]pyrazin-2-yl)-1,2-oxazole
CID 160960144
3-[1-[Dideuterio-(4-fluoro-4-methylcyclohexyl)methyl]-6-(3,5-dimethyl-1,2-oxazol-4-yl)pyrrolo[3,2-b]pyridin-3-yl]prop-2-yn-1-ol;5-[1-[dideuterio-(4-fluoro-4-methylcyclohexyl)methyl]-6-(3,5-dimethyl-1,2-oxazol-4-yl)pyrrolo[3,2-b]pyridin-3-yl]pyrazin-2-amine;4-[6-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[(1-fluorocyclohexyl)methyl]pyrrolo[3,2-b]pyridin-3-yl]benzoic acid;4-[1-[(4-fluoro-4-methylcyclohexyl)methyl]-3-[1-(2,2,2-trifluoroethyl)pyrazol-4-yl]pyrrolo[3,2-b]pyridin-6-yl]-5-methyl-1,2-oxazol-3-amine
CID 161475220
4-[3-[1-(2,2-Difluoropropyl)pyrazol-4-yl]-1-(pyridin-2-ylmethyl)pyrrolo[3,2-b]pyridin-6-yl]-3,5-dimethyl-1,2-oxazole;4-[3-[1-(2,2-difluoropropyl)pyrazol-4-yl]-1-(pyrimidin-2-ylmethyl)pyrrolo[3,2-b]pyridin-6-yl]-3,5-dimethyl-1,2-oxazole;4-[6-(3,5-dimethyl-1,2-oxazol-4-yl)-1-(1-pyridin-2-ylethyl)pyrrolo[3,2-b]pyridin-3-yl]benzoic acid;4-[3-[1-(1-fluoroethyl)pyrazol-4-yl]-1-(1-pyridin-2-ylethyl)pyrrolo[3,2-b]pyridin-6-yl]-3,5-dimethyl-1,2-oxazole;4-[3-[1-(1-fluoroethyl)pyrazol-4-yl]-1-(pyrimidin-2-ylmethyl)pyrrolo[3,2-b]pyridin-6-yl]-3,5-dimethyl-1,2-oxazole
CID 161483009
4-[3-benzyl-5-(3,5-dimethyl-1,2-oxazol-4-yl)pyrazolo[3,4-b]pyridin-1-yl]-3-fluorobenzoic acid;2-[1-(2,2-difluoropropyl)pyrazole-4-carboximidoyl]-5-(3,5-dimethyl-1,2-oxazol-4-yl)-N-[(1S)-1-pyridin-2-ylethyl]pyridin-3-amine;5-(3,5-dimethyl-1,2-oxazol-4-yl)-2-(1-methylpyrazole-4-carboximidoyl)-N-[(1S)-1-pyridin-2-ylethyl]pyridin-3-amine;1-[4-[6-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[phenyl(pyridin-2-yl)methyl]pyrazolo[4,3-b]pyridin-3-yl]phenyl]propan-2-one;ethyl 4-[[5-(3,5-dimethyl-1,2-oxazol-4-yl)-3-(2-phenylethanimidoyl)-2-pyridinyl]amino]-3-fluorobenzoate
CID 162214259
Methyl 4-[5-[2-[[5-(3,5-dimethyl-1,2-oxazol-4-yl)-4-methoxy-13-quinolin-4-yl-3,8,10,12-tetrazatricyclo[7.4.0.02,7]trideca-1(13),2(7),3,5,9,11-hexaen-11-yl]methyl]-3,5-dimethyl-1,2-oxazol-2-ium-4-yl]-4-methoxy-11-methyl-3,8,10,12-tetrazatricyclo[7.4.0.02,7]trideca-1(13),2(7),3,5,9,11-hexaen-13-yl]naphthalene-1-carboxylate
CID 123313177
4-[(3-cyclopropyl-1-ethylpyrazol-5-yl)amino]-7-(3,5-dimethyl-1,2-oxazol-4-yl)-N-[2-[2-[3-[[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]amino]propyl]-1H-imidazol-5-yl]ethyl]-6-methyl-9H-pyrimido[4,5-b]indole-2-carboxamide
CID 147018211
4-[(3-cyclopropyl-1-ethylpyrazol-5-yl)amino]-7-(3,5-dimethyl-1,2-oxazol-4-yl)-N-[3-[2-[2-[[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]amino]ethyl]-1H-imidazol-5-yl]propyl]-6-methyl-9H-pyrimido[4,5-b]indole-2-carboxamide
CID 147936904
4-[(3-cyclopropyl-1-ethylpyrazol-5-yl)amino]-7-(3,5-dimethyl-1,2-oxazol-4-yl)-N-[3-[2-[3-[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]propyl]-1H-imidazol-5-yl]propyl]-6-methyl-9H-pyrimido[4,5-b]indole-2-carboxamide
CID 149557433

Frequently Asked Questions

What is the IUPAC name of [4-[4-(3,5-dimethyl-1,2-oxazol-4-yl)-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-1H-indol-6-yl]methanol;4-[4-(1,4-dimethylpyrazol-5-yl)-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-1H-indole-6-carboxylic acid;(3R)-4-[6-(3,5-dimethyltriazol-4-yl)-2-(6-methyl-1H-indol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[4-(3,5-dimethyltriazol-4-yl)-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)-2-pyridinyl]-3-methylmorpholine?
The IUPAC name of [4-[4-(3,5-dimethyl-1,2-oxazol-4-yl)-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-1H-indol-6-yl]methanol;4-[4-(1,4-dimethylpyrazol-5-yl)-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-1H-indole-6-carboxylic acid;(3R)-4-[6-(3,5-dimethyltriazol-4-yl)-2-(6-methyl-1H-indol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[4-(3,5-dimethyltriazol-4-yl)-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)-2-pyridinyl]-3-methylmorpholine (CID 159914441) is [4-[4-(3,5-dimethyl-1,2-oxazol-4-yl)-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-1H-indol-6-yl]methanol;4-[4-(1,4-dimethylpyrazol-5-yl)-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-1H-indole-6-carboxylic acid;(3R)-4-[6-(3,5-dimethyltriazol-4-yl)-2-(6-methyl-1H-indol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[4-(3,5-dimethyltriazol-4-yl)-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)-2-pyridinyl]-3-methylmorpholine.
What is the SMILES notation for [4-[4-(3,5-dimethyl-1,2-oxazol-4-yl)-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-1H-indol-6-yl]methanol;4-[4-(1,4-dimethylpyrazol-5-yl)-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-1H-indole-6-carboxylic acid;(3R)-4-[6-(3,5-dimethyltriazol-4-yl)-2-(6-methyl-1H-indol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[4-(3,5-dimethyltriazol-4-yl)-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)-2-pyridinyl]-3-methylmorpholine?
The canonical SMILES for [4-[4-(3,5-dimethyl-1,2-oxazol-4-yl)-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-1H-indol-6-yl]methanol;4-[4-(1,4-dimethylpyrazol-5-yl)-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-1H-indole-6-carboxylic acid;(3R)-4-[6-(3,5-dimethyltriazol-4-yl)-2-(6-methyl-1H-indol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[4-(3,5-dimethyltriazol-4-yl)-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)-2-pyridinyl]-3-methylmorpholine is Cc1cc(-c2nc(-c3c(C)nnn3C)cc(N3CCOC[C@H]3C)n2)c2cc[nH]c2c1.Cc1cnn(C)c1-c1cc(N2CCOC[C@H]2C)nc(-c2cc(C(=O)O)cc3[nH]ccc23)n1.Cc1nnn(C)c1-c1cc(-c2ccnc3[nH]ccc23)nc(N2CCOC[C@H]2C)c1.Cc1noc(C)c1-c1cc(N2CCOC[C@H]2C)nc(-c2cc(CO)cc3[nH]ccc23)n1.
What is the InChIKey of [4-[4-(3,5-dimethyl-1,2-oxazol-4-yl)-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-1H-indol-6-yl]methanol;4-[4-(1,4-dimethylpyrazol-5-yl)-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-1H-indole-6-carboxylic acid;(3R)-4-[6-(3,5-dimethyltriazol-4-yl)-2-(6-methyl-1H-indol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[4-(3,5-dimethyltriazol-4-yl)-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)-2-pyridinyl]-3-methylmorpholine?
The InChIKey is NXPFRDUZLXXKSK-VIZKOGMYSA-N. The full InChI is InChI=1S/C23H24N6O3.C23H25N5O3.C22H25N7O.C21H23N7O/c1-13-11-25-28(3)21(13)19-10-20(29-6-7-32-12-14(29)2)27-22(26-19)17-8-15(23(30)31)9-18-16(17)4-5-24-18;1-13-12-30-7-6-28(13)21-10-20(22-14(2)27-31-15(22)3)25-23(26-21)18-8-16(11-29)9-19-17(18)4-5-24-19;1-13-9-17(16-5-6-23-18(16)10-13)22-24-19(21-15(3)26-27-28(21)4)11-20(25-22)29-7-8-30-12-14(29)2;1-13-12-29-9-8-28(13)19-11-15(20-14(2)25-26-27(20)3)10-18(24-19)16-4-6-22-21-17(16)5-7-23-21/h4-5,8-11,14,24H,6-7,12H2,1-3H3,(H,30,31);4-5,8-10,13,24,29H,6-7,11-12H2,1-3H3;5-6,9-11,14,23H,7-8,12H2,1-4H3;4-7,10-11,13H,8-9,12H2,1-3H3,(H,22,23)/t14-;13-;14-;13-/m1111/s1.
What are the key properties of [4-[4-(3,5-dimethyl-1,2-oxazol-4-yl)-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-1H-indol-6-yl]methanol;4-[4-(1,4-dimethylpyrazol-5-yl)-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-1H-indole-6-carboxylic acid;(3R)-4-[6-(3,5-dimethyltriazol-4-yl)-2-(6-methyl-1H-indol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[4-(3,5-dimethyltriazol-4-yl)-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)-2-pyridinyl]-3-methylmorpholine?
[4-[4-(3,5-dimethyl-1,2-oxazol-4-yl)-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-1H-indol-6-yl]methanol;4-[4-(1,4-dimethylpyrazol-5-yl)-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-1H-indole-6-carboxylic acid;(3R)-4-[6-(3,5-dimethyltriazol-4-yl)-2-(6-methyl-1H-indol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[4-(3,5-dimethyltriazol-4-yl)-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)-2-pyridinyl]-3-methylmorpholine has a molecular weight of 1644.92 g/mol, XLogP of 13.09, 14 rotatable bonds, 6 hydrogen bond donors, and 28 hydrogen bond acceptors.
Where does this data come from?
All data for [4-[4-(3,5-dimethyl-1,2-oxazol-4-yl)-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-1H-indol-6-yl]methanol;4-[4-(1,4-dimethylpyrazol-5-yl)-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-1H-indole-6-carboxylic acid;(3R)-4-[6-(3,5-dimethyltriazol-4-yl)-2-(6-methyl-1H-indol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[4-(3,5-dimethyltriazol-4-yl)-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)-2-pyridinyl]-3-methylmorpholine is sourced from PubChem (CID 159914441), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).